Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,680 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophrenia.
Nakajima S, Takeuchi H, Plitman E, Fervaha G, Gerretsen P, Caravaggio F, Chung JK, Iwata Y, Remington G, Graff-Guerrero A. Nakajima S, et al. Among authors: takeuchi h. Schizophr Res. 2015 May;164(1-3):164-75. doi: 10.1016/j.schres.2015.01.043. Epub 2015 Feb 13. Schizophr Res. 2015. PMID: 25684554 Free PMC article. Review.
Bone mineral density measurement in female inpatients with schizophrenia.
Kishimoto T, Watanabe K, Takeuchi H, Kikuchi T, Nakajima S, Shimada N, Yagi G, Kashima H. Kishimoto T, et al. Among authors: takeuchi h. Schizophr Res. 2005 Sep 1;77(1):113-5. doi: 10.1016/j.schres.2005.02.011. Schizophr Res. 2005. PMID: 16005393 No abstract available.
Effectiveness of antipsychotic polypharmacy for patients with treatment refractory schizophrenia: an open-label trial of olanzapine plus risperidone for those who failed to respond to a sequential treatment with olanzapine, quetiapine and risperidone.
Suzuki T, Uchida H, Watanabe K, Nakajima S, Nomura K, Takeuchi H, Tanabe A, Yagi G, Kashima H. Suzuki T, et al. Among authors: takeuchi h. Hum Psychopharmacol. 2008 Aug;23(6):455-63. doi: 10.1002/hup.959. Hum Psychopharmacol. 2008. PMID: 18537222 Clinical Trial.
A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous tapering.
Takeuchi H, Suzuki T, Uchida H, Nakajima S, Nomura K, Kikuchi T, Manki H, Watanabe K, Kashima H. Takeuchi H, et al. J Clin Psychopharmacol. 2008 Oct;28(5):540-3. doi: 10.1097/JCP.0b013e3181842586. J Clin Psychopharmacol. 2008. PMID: 18794650 Clinical Trial.
Impacts of switching antidepressants after successful electroconvulsive therapy on the maintenance of clinical remission in patients with treatment-resistant depression: a chart review.
Nakajima S, Ishida T, Akaishi R, Takahata K, Kitahata R, Uchida H, Suzuki T, Takeuchi H, Nomura K, Nakagawa A, Watanabe K, Kashima H. Nakajima S, et al. Among authors: takeuchi h. J ECT. 2009 Sep;25(3):178-81. doi: 10.1097/YCT.0b013e3181a8e2ac. J ECT. 2009. PMID: 19710625
Magnitude of rater differences in assessment scales for schizophrenia.
Suzuki T, Takeuchi H, Nakajima S, Nomura K, Uchida H, Yagi G, Watanabe K, Kashima H. Suzuki T, et al. Among authors: takeuchi h. J Clin Psychopharmacol. 2010 Oct;30(5):607-11. doi: 10.1097/JCP.0b013e3181f0bae1. J Clin Psychopharmacol. 2010. PMID: 20814326 Clinical Trial.
3,680 results